Invivyd (IVVD) Equity Average (2021 - 2025)
Invivyd (IVVD) reported Equity Average of $167.3 million for Q4 2025, up 122.04% on a YoY basis from $75.4 million in Q4 2024, and up 146.29% quarter-over-quarter from $67.9 million in Q3 2025.
Invivyd (IVVD) Equity Average (2021 - 2025) Analysis & Trends
Invivyd has reported Equity Average for 5 years, with the latest figure at $167.3 million in Q4 2025.
- For the quarter ending Q4 2025, Equity Average rose 122.04% year-over-year to $167.3 million; the trailing twelve-month figure through Dec 2025 stood at $167.3 million (up 122.04% YoY), and the FY2025 full-year result was $154.5 million, up 26.15% from the prior year.
- Equity Average for Q4 2025 stood at $167.3 million, up from $67.9 million in the prior quarter.
- The five-year high for Equity Average was $595.6 million in Q4 2021, with the low at -$124.0 million in Q2 2021.
- Historically, Equity Average has averaged $216.6 million across 5 years, with a median of $195.0 million in 2023.
- Annual changes were most pronounced in 2022 — Equity Average surged 703.41% — and 2025, when it plunged 69.63%.
- Invivyd's Equity Average stood at $595.6 million in 2021, then plunged by 38.43% to $366.7 million in 2022, then sank by 42.19% to $212.0 million in 2023, then sank by 64.45% to $75.4 million in 2024, then jumped by 122.04% to $167.3 million in 2025.
- The last three Equity Average figures came in at $167.3 million (Q4 2025), $67.9 million (Q3 2025), and $48.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 167.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 167.30 Mn |
| Sep 30, 2025 | 67.93 Mn |
| Jun 30, 2025 | 48.47 Mn |
| Mar 31, 2025 | 60.84 Mn |
| Dec 31, 2024 | 75.35 Mn |
| Sep 30, 2024 | 111.90 Mn |
| Jun 30, 2024 | 159.57 Mn |
| Mar 31, 2024 | 177.98 Mn |
| Dec 31, 2023 | 211.98 Mn |
| Sep 30, 2023 | 264.03 Mn |
| Jun 30, 2023 | 304.16 Mn |
| Mar 31, 2023 | 341.36 Mn |
| Dec 31, 2022 | 366.71 Mn |
| Sep 30, 2022 | 396.14 Mn |
| Jun 30, 2022 | 437.12 Mn |
| Mar 31, 2022 | 508.71 Mn |
| Dec 31, 2021 | 595.62 Mn |
| Sep 30, 2021 | 244.29 Mn |
| Jun 30, 2021 | -123.99 Mn |
| Mar 31, 2021 | -84.31 Mn |